Drug profile · INN
ergocalciferol
ERGOCALCIFEROL
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
ergocalciferol (ERGOCALCIFEROL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12358976
Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d
granted -
US 12214021
Study on lactoferrin regulation of bone formation by means of vitamin D receptor
granted -
US 11903952
Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection
granted -
US 10258635
Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseases
granted -
US 8785421
Use of vitamin D in dairy mastitis treatment
granted -
US 7361664
Vitamin D receptor antagonists and related compositions and methods of use
granted -
US 6610866
Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
expired -
US 6329357
Therapeutically effective 1.alpha., 25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
expired
Frequently asked questions
What is ergocalciferol?
ergocalciferol (ERGOCALCIFEROL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ergocalciferol?
ERGOCALCIFEROL is a marketed brand name for ergocalciferol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ergocalciferol?
ergocalciferol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.